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A B S T R A C T
Aim: Chlordecone is able to induce pro-angiogenic effect through an estrogen receptor (ERα) pathway involving
NO release and VEGF. The present study aimed to determine the molecular mechanisms by which chlordecone
promotes angiogenesis in human endothelial cells.
Results: High but not low concentration of chlordecone increased mitochondrial respiratory capacity and mi-
tochondrial DNA content in endothelial cells. The ROS scavenger MnTMPyP was able to prevent the increase of
both VEGF expression and capillary length induced by chlordecone. A significant increase of cytoplasmic O2%−
production was observed after 1 and 4 h incubation of chlordecone, but not after 2 h. The NADPH oxidase
inhibitor apocynin or silencing p47phox prevented angiogenesis and tube formation but also the increase in
production of O2%− at 1 h. In addition, apocynin as well silencing p47phox prevented eNOS activation and the
NO synthase inhibitor L-NAME inhibited mitochondrial O2%−production. All the previous effects of chlordecone
were prevented by fulvestrant.
Conclusion: Our results indicate that an adaptation of the mitochondrial energy metabolism occurs in the
chlordecone angiogenic response. Finally, we showed that chlordecone induces endothelial cells angiogenesis by
a cross-talk involving NADPH oxidase and mitochondrial O2%− via a NO sensitive pathways through activation
of ERα. These findings propose that a molecular mechanism may partly explain the epidemiological evidence
implicating chlordecone as risk factor carcinogenesis.
1. Introduction
Chlordecone is an organochlorine pesticide which causes significant
environmental and human health concerns. The use of chlordecone on
French Antilles banana plantations between 1973 and 1993 produced
massive contamination of soil and river water thereby affecting largely
male workers. A study carried out by Multigner et al. (Multigner et al.,
2010) has clearly determined that chlordecone is associated with risk of
prostate cancer in exposed individuals. Its high lipophilicity has re-
sulted in bioaccumulation in various organisms through the food chain,
and chlordecone and its metabolites have been detected in the blood,
adipose tissue and prostate explaining the possible influence of this
chemical on tumor development or other pathophysiological situations
in which angiogenesis plays an important role (Miller, 2004; Band
et al., 2011; Shakeel et al., 2010; Hillon et al., 2010). Angiogenesis,
defined as the formation of new blood vessels from nearby pre-existing
capillaries, represents an essential step in tumor development and
metastasis (Risau, 1997). We have recently demonstrated that chlor-
decone exposure at concentration found in the drinking water and in
the plasma of exposed patients promotes angiogenesis. Indeed, in vitro
HUVEC model, chlordecone enhanced capillary-like formation through
an increase in cell proliferation, migration and adhesion (Clere et al.,
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2012). We have attributed this pro-angiogenic to the release of nitric
oxide (NO) and to vascular endothelial growth factor (VEGF) produc-
tion via an estrogen receptor alpha (ERα)-dependent pathway. How-
ever, the precise mechanisms by which chlordecone exposure induces
angiogenic effect remain to be clarified. Since reactive oxygen species
(ROS) have been shown to have the capacity to regulate angiogenesis in
many situations, we have tested the hypothesis that exposure to
chlordecone may induce ROS production in endothelial cells (EC). As
mitochondria is both a main source of ROS and a source of ATP in EC,
the role of this organelle in the endergonic process caused by chlor-
decone has been investigated.
The low content of mitochondria in endothelial cells suggests that
producing energy is not the main function of mitochondria in these cells
(Kluge et al., 2013). Effectively, vessel sprouting by ECs during angio-
genesis was shown to rely on glycolysis rather than on oxidative
phosphorylation for ATP production (De Bock et al., 2013; Eelen et al.,
2013; Cantelmo et al., 2015). Nevertheless, some studies have reported
that the energetic function performed by mitochondria may play a role
in the angiogenic process. For example, it was demonstrated that an-
giogenic signaling factors may regulate mitochondrial biogenesis
(Wright et al., 2008) or mitochondrial dynamic (Lugus et al., 2011) and
recently, we have observed that the in vitro angiogenic effect of a low
dose red wine polyphenols was associated with an increase of mi-
tochondrial oxidative capacity (Duluc et al., 2013). These results thus
led us to consider a contribution of mitochondrial bioenergetics to
chlordecone induced angiogenesis that was explored in this study.
In contrast to their limited role to supply energy, mitochondria in
endothelium play an important regulatory role through the production
of ROS. Mitochondria derived-ROS can activate a wide range of cellular
programs including angiogenesis. For example, mitochondrial ROS
production has been reported to play a crucial role in arsenic-regulated
angiogenesis by stabilizing hypoxia-inducible factor (Li et al., 2014).
Moreover recent evidence suggests a crosstalk between mitochondria
and NADPH oxidase the other main EC source of ROS in the regulation
of mitochondrial ROS production (Dikalov, 2011). For instance, NOX2
was found to induce production of mitochondrial superoxide in an-
giotensin II- mediated endothelial oxidative stress (Doughan et al.,
2008; Dikalov et al., 2014a). Thus, the aim of the present study is to
determine if chlordecone induces mitochondrial biogenesis and if a
redox sensitive pathway implying a crosstalk between NADPH oxidase
and mitochondria is involved in its pro-angiogenic effect in the sig-
naling pathway. This would help identify potentially useful targets in
the management of cancer subjects exposed to the organochlorine
pesticide.
2. Materials and methods
2.1. Chemicals
Chlordecone (Sigma Aldrich St. Quentin Fallavier, France) was used
at concentration found in the drinking water (2× 10−11 M) and in the
plasma of exposed patients (5×10−8 M) and dissolved in 0.1% di-
methylsulfoxide cell culture medium. Superoxide dismutase (SOD)
mimetic, manganese (III)tetrakis-(1-methyl-4-pyridyl)-porphyrin pen-
tachloride (MnTMPyP), anti-β-actin antibody and inhibitors of ER
(fulvestrant), NOS (nitro-L-arginine methylester, L-NAME), NADPH
oxidase (apocynin), mitochondrial complexes I, III (rotenone and an-
timycin), mitochondrial respiration (oligomycin and antimycin A) and
a decoupling agent carbonyl cyanide 4-trifluoromethoxy phenylhy-
drazone (FCCP) were purchased from Sigma Aldrich (St. Quentin
Fallavier, France). Human VEGF, anti-VEGF, anti-p47phox, anti-
phospho-eNOS-Ser1177 and anti-eNOS antibodies were from Santa
Cruz Biotechnology (Santa Cruz CA). Si-RNA anti-p47phox and mi-
tochondria-targeted scavenger mito-TEMPO were purchased from BD
bioscience (Santa Cruz, Biotechnology). MitoNeo was gracefully pro-
vided by Prof. Richard C. Hartley and Dr. Stuart Caldwell from the
School of Chemistry, University of Glasgow.
2.2. Cell culture
Human umbilical vein endothelial cells (HUVECs) from newborn
males were obtained from Lonza (Basel, Switzerland). The cells were
cultured in plastic flasks Cellbind® in endothelial cell growth medium
(EGM-2) from Lonza, containing 1% L-glutamine, 1% streptomycin/
penicillin, 500 ng/L epidermal growth factor, 1 g/L basic fibroblast
growth factor (bFGF), supplemented with 10% fetal bovine serum (FBS)
heat inactivated. The HUVECs were used from the second to fifth pas-
sage.
Cells were treated with MnTMPyP (10−2 M), fulvestrant,
(3× 10−8 M), rotenone (5×10−6 M), antimycin (2.5× 10−6 M), L-
NAME (10−4 M), apocynin (10−4 M), an inhibitor of NADPH oxidase or
mitochondria targeted scavenger mito-TEMPO (2.5×10−8 M) 30min
before the stimulation with chlordecone (2× 10−11 M and
5×10−8 M). All agents were used at concentrations at which no cy-
totoxicity was previously observed (Duluc et al., 2013; Mostefai et al.,
2008).
2.3. Measurement of whole cell respiration
In order to measure the rate of respiration, the HUVECs cells were
stimulated with chlordecone (2× 10−11 M and 5×10−8 M) in the
presence or absence of fulvestrant (3×10−8 M) for 24 h. The cells
were trypsinized, washed once in culture medium and centrifuged
(500g 5min). The pellet was resuspended in respiratory medium EGM-
2. Mitochondrial oxygen consumption was recorded at 37 °C using a
high-resolution oxygraph–2 K respirometer (Oroboros, Innsbruk,
Austria). The measurement of basal respiration, non-phosphorylating
respiration, the ability of the respiratory chain without regulation
performed by the ATP synthase, the respiratory control ratio (RCR), the
phosphorylating respiratory control ratio (RCRp) and the uncoupling
control ratio (UCR) were performed as described by Duluc. (Duluc
et al., 2013).
2.4. RNA extraction and quantitative PCR analysis (qPCR)
After treatment, total RNA was isolated form cells using RNA ex-
traction kit Macherey-Nagel (Hoerdt, France). The quantification of
gene expression of peroxisome proliferative activated receptor-co-acti-
vator 1 (PGC1-α), estrogen-related receptor alpha (ERRα), the nuclear
respiratory factor-1 (NRF-1), mitochondrial transcription factor A
(Tfam) were performed as previously described by (Duluc et al., 2013).
2.5. Quantification of the mitochondrial DNA content
After treatment, total DNA was isolated from endothelial cells. The
mitochondrial DNA (mtDNA) copy number was determined by qPCR as
previously described by (Duluc et al., 2013).
2.6. In vitro capillary network formation on ECM gel®
After 24 h incubation with chlordecone (2× 10−11 M and
5×10−8 M) in the presence or absence of apocynin (10−4 M),
MnTMPyP (10−2 M) and mito-TEMPO (2.5× 10−8 M), HUVECs were
detached with trypsin ethylenediaminetetraacetic acid (EDTA). The
cells were seeded with a density of 1.5× 105 cells per well precoated
with ECM gel® (Sigma-Aldrich). Briefly, 1.5× 10−4 L of ECM® was
added into a four-well plate and allowed to solidify for 1 h at 37 °C.
Then, cells are incubated with medium containing 10% FBS and al-
lowed to adhere for 1 h after which the different stimuli were added.
Tube formation was examined by phase-contrast microscopy (MOTIC
AE21) after 24 h and average length of capillaries was quantified using
ImageJ software for evaluation of angiogenesis.
E. Alabed Alibrahim et al. International Journal of Biochemistry and Cell Biology 97 (2018) 83–97
84
2.7. Western blot
After treatment with chlordecone (2×10−11 M and 5×10−8 M) in
the presence or absence of apocynin (10−4 M), L-NAME (10−4 M),
siRNAp47phox and MnTMPyP (10−2 M), mito-TEMPO (2.5× 10−8 M),
the cells were homogenized, washed twice with PBS and trypsinized.
The cells were lysed by RIPA buffer with the following composition:
(2× 10−2 M Tris-HCL (pH 7.5), 1.5× 10−1 M NaCl, 10−3 M Na2
EDTA, 10−3 M EGTA, 1% NP-40, 0,5% sodium deoxycholate,
2.5× 10−3 M sodium pyrophosphate, 10−3 M β-glycerophosphate,
10−3 M Na3VO4) in presence of protease inhibitor. Cells were allowed
to lyse for 45min on ice and centrifuged at 15000g for 15min at 4 °C.
The supernatant was removed, and protein concentrations in the su-
pernatant were determined by protein assay.
Fig. 1. Mitochondrial effects of chlordecone on endothelial cells. Effects of chlordecone (2×10−11 M and 5×10−8M) were studied on mitochondrial respiration (A,B,C), mtDNA
content (D) and gene expression of mitochondrial biogenesis factors (E,F,G) in HUVECs after 24 h of stimulation with either DMSO (white columns), chlordecone 2×10−11 M (light-gray
columns) or 5× 10−8 M (dark-gray columns). Data are means ± SEM of eight independent experiments. * p < 0.05 versus DMSO. ** p < 0.01 versus DMSO.
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The proteins (30× 10−6 g) were separated on 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
on the nitrocellulose membranes. The membranes were incubated with
anti-VEGF, anti-p47phox, anti-phospho-eNOS-Ser1177 and anti-eNOS
antibodies overnight at 4 °C. The anti-β-actin (Sigma-Aldrich) was used
to visualize protein gel loading. The membranes were then incubated
with appropriate horseradish peroxidase-conjugated secondary anti-
body. The protein-antibody complexes were detected by chemilumi-
nescence using the Western Blotting Luminol reagent kit (Santa Cruz
Biotechnology®).
2.8. Superoxide anion (O2%−) quantification by electron paramagnetic
resonance (EPR)
For O2%− quantification, cells were treated with chlordecone
(2× 10−11 M and 5×10−8 M) for 1, 2 and 4 h in the presence or
absence of apocynin (10−4 M), L-NAME (10−4 M), rotenone
(5× 10−6 M), antimycin (2.5× 10−6 M), siRNAp47phox and fulves-
trant (3×10−8 M). Cells were allowed to equilibrate in deferoxamine-
chelated Krebs-Hepes solution containing 1-hydroxy-3methox-
ycarbonyl-2,2,5,5-tetramethylpyrolidin (CMH; Noxygen, Mainz,
Germany) (5×10−4 M), deferoxamine (2.5× 10−5 M), and DETC
(sodium diethyl thiocarbamate trihydrate (5×10−6 M) under constant
temperature (37 °C) for 45min. Cells were then scrapped, frozen in
plastic tubes and then analyzed by EPR spectroscopy. Values are ex-
pressed as units/μg.μL of proteins.
2.9. Detection of mitochondrial superoxide anion (mtROS) by confocal
microscopy
For detection of cells were treated with chlordecone (2×10−11 M
and 5× 10−8 M) at 1 and 4 h in the presence or absence of apocynin
(10−4 M), L-NAME (10−4 M), siRNAp47phox and fulvestrant
(3× 10−8 M). Cells were washed twice with PBS and incubated in
Krebs containing 5× 10−6 M Mitosox® red (a marker for mitochondrial
O2%−) for 10min, and then the cells were fixed by 4% paraformalde-
hyde during 15min incubation at 37 °C. The cells were incubation with
DAPI blue 3.6×10−6 M (a marker of the nucleus) at room temperature
for 15min. The wavelengths of excitation and emission are 510/580 nm
and 340/488 for Mitosox® and DAPI respectively. The images obtained
by confocal microscopy were imported into the image J software and
the density of the fluorescence was analyzed.
In some experiments, mitochondrial levels of anion superoxide were
measured using the MitoNeoD probe) (Shchepinova et al., 2017). Mi-
toNeo was extemporaneously reduced to MitoNeoD before each ex-
periment as previously described. Cells were loaded with 10× 10−6 M
MitoNeoD for 45min, and were then treated with chlordecone
(2× 10−11 M and 5×10−8 M) for 1 or 4 h in presence or absence of
2.5× 10−8 M of the mitochondria-targeted antioxidant MitoTempo
(2.5×10−8 M) (Sigma-Aldrich). Reaction of MitoNeoD with O2%−
generates MitoNeoOH. Thus, MitoNeoOH formation was directly
monitored by recording the fluorescence intensity on a Clariostar
spectrofluorimeter microplate reader (BMG LabTech), using 544 nm
excitation and 605 nm emission wavelengths.
2.10. Statistical analysis
Data are presented as mean ± SEM, n represents the number of
experiments repeated at least in triplicate. Statistical analyses were
performed by ANOVA followed by a Bonferroni test. p < 0.05 was
considered to be statistically significant.
3. Results
3.1. High but not low concentration of chlordecone increases mitochondrial
biogenesis
Mitochondrial respiration was studied after stimulation of HUVECs
with both chlordecone concentrations for 24 h. Chlordecone at low
concentration did not significantly modify the basal, oligomycin and
FCCP-sensitive respirations. We only observed a trend of increasing
maximal oxygen consumption upon addition of the uncoupler FCCP
(Fig. 1A–C). However, chlordecone at high concentration increased
basal, oligomycin and FCCP-sensitive respirations (Fig. 1A–C). The in-
crease in mitochondrial respiration by high chlordecone concentration
was not associated with changes in different ratios, RCR, RCRp and
UCR (not shown), indicating that this concentration of chlordecone
probably increased mitochondrial mass. To confirm this, mtDNA con-
tent was quantified. High but not low concentration of chlordecone
increased the mtDNA content in ECs (Fig. 1D).
To determine whether the increase of mitochondrial mass induced
by high chlordecone concentration was associated with an increased
mitochondrial biogenesis, the expression of genes implicated in mi-
tochondrial biogenesis was explored using qPCR 24 h after exposure.
Gene expression of PGC1α downstream transcription factors was only
detected in these cells. If low concentration chlordecone did not mod-
ulate the expression of NRF1, ERRα and Tfam, high chlordecone con-
centration increased their expression (Fig. 1E–G). Collectively, these
results suggest that endothelial cells adapt their mitochondrial energy
metabolism when shifting from quiescence to rapid growth during an-
giogenesis.
3.2. Chlordecone promotes angiogenesis in a MnTMPyP-sensitive manner
As ROS have been identified as playing a role in various signaling
pathways in endothelial cells, including angiogenesis, we next de-
termined whether ROS were implicated in the pro-angiogenic effect of
chlordecone. As shown in Fig. 2A and B, the ROS scavenger MnTMPyP
(10−2 M), did not have an effect when added alone but it was able to
prevent the increase of both VEGF expression and capillary length in-
duced by chlordecone (2×10−11 M and 5× 10−8 M). These results
suggest that chlordecone induces angiogenesis by a ROS dependent
mechanism.
3.3. Chlordecone promotes angiogenesis through a sequential regulation of
cytoplasmic and mitochondrial O2%− production
To identify the source of ROS implicated in the pro-angiogenic ef-
fect of chlordecone, production of cytoplasmic and mitochondrial ROS
were measured after treatment of HUVECs with chlordecone
(2×10−11 M and 5× 10−8 M) at different time points (1, 2, and 4 h).
Cytoplasmic O2%−, were quantified using EPR. A significant increase of
cytoplasmic O2%− production was observed at 1 and 4 h (Fig. 3A and
C). Chlordecone (2×10−11 M and 5× 10−8 M) didn’t modulate the
production of cellular O2%− at 2 h (Fig. 3B). Mitochondrial O2%− levels
were evaluated with both the generally used mitochondria-specific
fluorescent probe MitoSOX (Fig. 3D and E) and also with MitoNeoD, a
new probe, recently developed to limit probe intercalation in the DNA
(Fig. 3F and G). Even if, as reported, the increase fluorescence upon
oxidative of mitoNeoD is less than for MitoSOX) (Shchepinova et al.,
2017), results going in the same direction with both probes were ob-
served suggesting that mitochondria are involved in the O2%− pro-
duction at 4 h but not at 1 h or 2 h (data not shown). In addition, the
effect of chlordecone on mitoNeoD fluorescence at 1 h and at 4 h was
evaluated on cells initially preincubated with mito-TEMPO. As reported
in Fig. 3F and G, the pretreatment with the mitochondria targeted
scavenger was able to prevent the increase in fluorescence of MitoNeoD
observed at 4 h without affecting the fluorescence at 1 h confirming the
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Fig. 2. Reactive oxygen species are involved in angiogenesis induced by chlordecone. Effects of manganese (III) tetrakis(1-methyl-4-pyridyl) porphyrin (MnTMPyP), a superoxide
dismutase mimetic (10−2 M) were studied on in vitro capillary-like structures length (A) and on the VEGF expression (B) using HUVECs after 24 h of stimulation with either DMSO (white
columns), chlordecone 2× 10−11 M (light-gray columns) or 5× 10−8M (dark-gray columns). Data are means ± SEM of six independent experiments. *p < 0.05 versus DMSO,
£p < 0.05 versus chlordecone 2×10−11 M, $p < 0.05 versus chlordecone 5× 10−8 M.
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mitochondrial origin of the O2%− production at 4 h.
3.4. Pro-angiogenic effect of chlordecone is regulated by O2%− production
from NADPH oxidase
NADPH oxidase is an important source of early ROS production in
endothelial cells (Fig. 3F and G) (Dikalov et al., 2014b; Ushio-Fukai,
2006; Frey et al., 2009);. Thus, the cytoplasmic O2%− production at 1 h
induced by both chlordecone concentrations could be related to NADPH
oxidase activity. To test this possibility, the production of cellular O2%−
was monitored by EPR in the presence of apocynin (10−4 M) an in-
hibitor of NADPH oxidase (Fig. 4A). As previously described, (Johnson
Fig. 3. Chlordecone promotes angiogenesis through a sequential regulation of cytoplasmic and mitochondrial O2−. Effects of chlordecone on cytosolic O2− (A: 1 h, B: 2 h and C: 4 h) and
mitochondrial O2− production measured by mitoSOX labeling (D: 1 h, E: 4 h), were studied after stimulation of HUVECs with either DMSO (white columns), chlordecone 2× 10−11 M
(light-gray columns) or 5× 10−8M (dark-gray columns). F, G: Effect of chlordecone on mitochondrial O2− production measured by MitoNeoD in absence or presence of the ROS
scavenger Mito-TEMPO. Data are means ± SEM of six independent experiments with mitoSOX and four with MitoNeoD. *p < 0.05 versus DMSO, ** p < 0.01 versus DMSO.
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et al., 2002), apocynin reduced the basal cytoplasmic O2%− production.
Apocycin was also able to prevent the increase in production of cellular
O2%− induced by both concentrations of chlordecone. Moreover, rote-
none and antimycin, inhibitor respectively of the complex I and III of
the respiratory chain equally blocked the early ROS production
(Fig. 4B).
It has been reported that the key post-translational modifications
involved in oxidase activation of Nox1/2, are the phosphorylation of
p47phox (Frey et al., 2009). To confirm that Nox was the major source of
O2%− production in our cellular model, p47phox was silenced with a
specific siRNA 72 h before cells exposition to chlordecone. As evidenced
in Fig. 4C, silencing p47phox abrogated chlordecone-stimulated pro-
duction of cytoplasmic O2%− at one hour confirming that Nox1/2 was
the major source of chlordecone-induced cytoplasmic O2%− at this
time.
To evaluate the involvement of O2%− production by NADPH oxi-
dase in the process of the formation of capillaries, we assayed VEGF
expression and capillary formation in the presence or absence apocynin
(10−4 M) for 24 h (Fig. 5A and B). Apocynin (10−4 M) prevented the
increase in length of capillary and synthesis of VEGF induced by
chlordecone (2×10−11 M and 5×10−8 M) suggesting that O2%−
derived from NADPH oxidase played a key role in the pro-angiogenic
Fig. 4. Effects of inhibitors of ROS sources on O2−
production after 1 h of chlordecone exposition.
Effects of NADPH oxidase inhibitor apocynin
(10−4 M) (A), of inhibitors of mitochondrial re-
spiratory chain rotenone (5× 10−6 M) and anti-
mycin (2.5×10−6 M) (B), of siRNA p47phox
(5×10−8 M) (C) on cytosolic O2− production at 1 h
were studied on HUVECs stimulated by either DMSO
(white columns), chlordecone 2× 10−11 M (light-
gray columns) or 5× 10−8M (dark-gray columns).
Cytosolic O2− was measured by EPR. Data are
means ± SEM of n= 6 or n=4 for mitochondrial
inhibition experiments * p < 0.05 versus DMSO, **
p < 0.01 versus DMSO, £p < 0.05 versus chlorde-
cone 2× 10−11 M; £££p < 0.001 versus chlordecone
2× 10−11 M, $$$p < 0.001 versus chlordecone
5× 10−8.
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effect of chlordecone.
3.5. Chlordecone promotes angiogenesis by regulating the production of
mitochondrial O2%− through NADPH oxidase and NOS inhibitor-sensitive
mechanisms
We therefore aimed to determine if NADPH oxidase would con-
tribute to chlordecone-induced mitochondrial O2%−. Apocynin as well
silencing p47phox prevented the increase in MitoSOX fluorescence
signal in chlordecone-stimulated HUVECs (Fig. 6A and B) confirming
that chlordecone (2× 10−11 M and 5× 10−8 M) induced mitochon-
drial O2%− production via an axis NADPH oxidase O2%−-release-mi-
tochondrial O2%−.
Chlordecone (2× 10−11 M and 5× 10−8 M) has also been shown
to promote NO production by increasing eNOS phosphorylation on its
activator site (Ser-1177). To assess the involvement of eNOS in this
redox signalisation, the production of cytoplasmic and mitochondrial
O2%− was measured in the presence of L-NAME (10−4 M), an inhibitor
of NOS (Fig. 7A–C). O2%− production at one hour was not affected by L-
NAME in contrast to production of cytoplasmic O2%− and mitochon-
drial O2%− at 4 h which were prevented. These results were consistent
with a role of NOS to stimulate mitochondrial O2%− production. Fur-
thermore, apocynin pretreatment inhibited the increase eNOS ser1177
phosphorylation induced by chlordecone (Fig. 7D). Finally, increasing
VEGF expression induced by chlordecone (2×10−11 M and
5×10−8 M) was prevented by treatment of HUVECs with L-NAME, an
inhibitor of NOS (Fig. 7E). Taken together, these results suggest that
pro-angiogenic effect of chlordecone (2×10−11 M and 5× 10−8 M)
depends on eNOS activity which was activated by NADPH oxidase-de-
rived-ROS. Altogether the results led us to suggest-that chlordecone
promotes angiogenesis by regulating the production of mitochondrial
O2%− through NADPH oxidase and eNOS activation.
Fig. 5. NADPH oxidase inhibitor apocynin prevents the chlordecone pro-angiogenic effect. Effects of inhibition of NADPH oxidase with apocynin (10−4 M) on in vitro capillary-like
structures length (A) and VEGF protein at 24 h (B) after stimulation of HUVECs with either DMSO (white columns), chlordecone 2×10−11 M (light-gray columns) or 5×10−8 M (dark-
gray columns). Data are means ± SEM of six independent experiments. ** p < 0.01 versus DMSO, ££p < 0.01 versus chlordecone 2× 10−11 M, $$p < 0.01 versus chlordecone
5× 10−8M.
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3.6. Mito-TEMPO was able to prevent the increase of both VEGF expression
and capillary length induced by chlordecone
To support the critical role of mitochondrial O2%− production in the
proangiogenic effect of chlordecone, we monitored the consequence of
Mito-TEMPO pretreatment on VEFG and capillary length formation. As
shown in Fig. 8A and B, mito-TEMPO did not have an effect when
added alone but it was able to prevent the increase of both VEGF ex-
pression and capillary length induced by chlordecone (2×10−11 M
and 5×10−8 M). The result confirms the importance of mitochondrial
O2− production in the signaling pathway.
3.7. Estrogen receptor activation is involved in all effects of chlordecone
Estrogen receptor is a key target involved in the angiogenesis in-
duced by chlordecone as we recently reported (Clere et al., 2012).
Therefore, we next questioned whether the chlordecone effects ob-
served on the mitochondrial capacity, cellular and mitochondrial O2%−
production were also related to ER activation. All the effects were not
observed in the presence of the ER-antagonist fulvestrant (Fig. 9A–F)
suggesting that estrogen receptor activation is probably the underlying
mechanism of the chlordecone effects.
4. Discussion
In the present study, we provide evidence that a redox crosstalk
between NADPH oxidase and mitochondria is involved in the proan-
giogenic activity of chlordecone. Most in detail, chlordecone induces
angiogenesis via a sequential increase of O2%− from NADPH oxidase
which in turn activates NO pathway leading to enhance mitochondrial
O2%− production. All of these effects concur to increase VEGF and
capillary formation. Of particular interest is the confirmation that
chlordecone mediates its effect via ER.
Even though the contribution of endothelial glycolysis to angio-
genesis is major, several recent studies have coupled angiogenesis and
mitochondrial function. For example, in mice muscle, surexpression of
PGC1α-b promotes mitochondrial biogenesis and enhances angiogen-
esis (Tadaishi et al., 2011). Here we showed that mitochondrial bio-
genesis is not required for chlordecone induced angiogenesis as low
concentration of chlordecone caused a marked increase in capillary
length without any significant change of mitochondrial respiration.
Nonetheless, we observed an adaptation of oxidative metabolismat with
at low chlordecone concentration a trend to an increase of FCCP sti-
mulated respiration and above all at a high concentration a mi-
tochondrial biogenesis. Given that VEGF signaling is known to stimu-
late mitochondrial biogenesis (Wright et al., 2008), it is possible that
explanation of the differential effects is a higher mitochondrial ROS
production induced by the high chlordecone concentration which may
Fig. 6. Chlordecone induced mitochondrial O2− production is regulated by NADPH oxidase. The effects of the NADPH oxidase inhibitor apocynin (10−4 M) and the siRNA p47phox
(5× 10−8 M) on mitochondrial O2− production at 4 h (A–B) were studied on HUVECs stimulated by either DMSO (white columns), chlordecone 2× 10−11 M (light-gray columns) or
5× 10−8M (dark-gray columns). Mitochondrial O2− production was measured by MitoSOX labeling. Data are means ± SEM of six independent experiments. * p < 0.05 versus DMSO,
** p < 0.01 versus DMSO, ££p < 0.01 versus chlordecone 2× 10−11 M, £££p < 0.001 versus chlordecone 2×10−11 M, $$$p < 0.001 versus chlordecone 5× 10−8M.
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Fig. 7. A NOS inhibitor-sensitive mechanism is involved in the production of-mitochondrial O2%−and the VEGF protein expression. The effects of L-NAME (10−4 M) on cytosolic O2%
production at one hour (A), at 4 h (B), on mitochondria O2% production (C), on eNOS protein and phosphorylation of Ser-1177 (D) and on VEGF protein expression (E) were studied in the
same conditions. Data are means ± SEM of six independent experiments. * p < 0.05 versus DMSO, ** p < 0.01 versus DMSO, # p< 0.05 versus L-NAME, ## p < 0.01 versus L-NAME.
££p < 0.01 versus chlordecone 2×10−11 M, $$p < 0.01 versus chlordecone 5× 10−8M. £££p < 0.001 versus chlordecone 2× 10−11 M, $$$p < 0.001 versus chlordecone
5× 10−8M.
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stimulate VEGF signaling in ECs. Conversely, in the condition of lower
chlordecone concentration, since VEGF signaling was shown to be
dispensable for the vessels formation, VEGF is susceptible to contribute
only to cell survival in a way that is independent of surface ligand/
receptor interactions as proposed by Domigan (Domigan et al., 2015).
Interestingly, it was suggested that in that case, VEGF maintains
Fig. 8. Effect of Mito-TEMPO pretreatment on the increase of both VEGF expression and capillary length induced by chlordecone (2× 10−11 M and 5×10−8 M).) Data are
means ± SEM of six independent experiments. ** p < 0.01 versus DMSO, £p < 0.05 versus chlordecone 2×10−11, ££p < 0.01 versus chlordecone 5× 10−8 M, $p < 0.05 versus
chlordecone 5× 10−11 M, $$p < 0.01 versus chlordecone 5×10−8 M.
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vascular homeostasis through regulation of the transcription factor
FOXO1 levels. Moreover, it was recently reported that the energetic
metabolic activity and growth state in the vascular endothelium may be
coupled by the regulation of MYC through FOXO1 (Wilhelm et al.,
2016). Remarkably, MYC overexpression stimulated both glycolysis and
mitochondrial respiration. Involvement of MYC in the effect of low
chlordecone concentration cannot be excluded and merits further in-
vestigation.
Besides the energetic role, a mitochondrial redox signaling
stimulated by an initial cytosolic O2%− production appears to be de-
terminant in the proangiogenic effect irrespective of chlordecone con-
centration. Indeed, intracellular pathways involved in the effect of
chlordecone show differential spatial and temporal regulation with
respect to cytosolic and mitochondrial pools of ROS.
In EC, cytoplasmic ROS can originate from several sources including
NADPH oxidase, xanthine oxidase and eNOS. Our data indicate that the
NADPH oxidase is the major site for the early O2%− production because
apocynin and most importantly silencing RNA-mediated knockdown of
Fig. 9. The effects chlordecone on mitochondrial respiration and ROS production are sensitive to ER antagonist. The effects of the ERα antagonist fulvestrant (3× 10−8M) on mi-
tochondrial respiration (A–C), on production of cytosolic O2% at 1 h and 4 h (D–E), on mitochondrial O2% production (F), were studied in the HUVECs after 24 h of stimulation with either
DMSO (white columns), chlordecone 2× 10−11 M (light-gray columns) or 5× 10−8M (dark-gray columns). Data are means ± SEM of six independent experiments. * p < 0.05 versus
DMSO, ** p < 0.01 versus DMSO, £££p < 0.001 versus chlordecone 2×10−11 M, $$p < 0.01 versus 5× 10−8M, $$$p < 0.001 versus chlordecone 5× 10−8 M, # p < 0.05 versus
fulvestrant, ## p < 0.01 versus fulvestrant.
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p47phox, an organizer subunit for Nox2/Nox1 (Drummond and Sobey,
2014) prevents the generation of O2%−. In addition, the early increase
on cytosolic ROS production was also prevented by rotenone and an-
timycin. The explanation for this is not clear and more work will be
required to more fully understand the consequence of inhibition of the
respiratory chain on NADPH oxidase activity. Whatever the exact me-
chanism underlying NADPH oxidase activation, NADPH oxidase ROS
production is as an important event as confirmed by the negative effect
of apocynin on VEGF expression and capillary formation. We are aware
of the fact that apocynin, a widely used inhibitor of NADPH is quite non
specific. Nevertheless, the fact that silencing p47 which is one of the
master subunit of NADPH linked to Nox-2 exhibits similar effects than
apocynin on the early increase in ROS production supports the in-
volvement of at least Nox-2 in the pathway This critical role of Nox1 or
Nox2 has been previously reported in both physiological and patholo-
gical angiogenesis (Kim and Byzova, 2014; Ushio-Fukai, 2007). NADPH
oxidase derived ROS were demonstrated to be an important mediator to
promote revascularization in an experimental ischemic hindlimb model
(Urao et al., 2013) as well as to facilitate the retinal VEGF expression
and neovascularization in a model of oxygen induced retinopathy in
mice (Chan et al., 2013). In addition, it was reported that neovascu-
larization in response to ischemia is inhibited in NOX2-/- mice and in
wild type mice treated with NADPH inhibitor apocynin. Collectively,
these data underline the importance of Nox2/Nox1 Nonetheless; we
cannot exclude the possibility that the co expressed in endothelial cells
Nox4 may also be involved. In line with that, Nox isoform Nox4 were
shown to stimulate mtROS production (Ago et al., 2010) and it was
recently reported that Nox4 can promote tumor angiogenesis (Helfinger
et al., 2016). Additional work is needed to determine the possible in-
teraction of these two NADPH oxidase isoforms in the chlordecone in-
duced angiogenesis.
Mitochondria are responsible for late-phase ROS production.
Inhibition of mitochondrial O2%− production by apocynin and siRNA
p47phox demonstrates an upstream role of NADPH oxidase in the acti-
vation of mitochondrial ROS. In addition, our data indicate that a more
direct downstream target of NADPH oxidase O2%− is most probably
eNOS. Indeed, L-NAME, an inhibitor of NOS, totally prevented mi-
tochondrial ROS production and angiogenesis without inhibiting the
production of O2%− from NADPH oxidase. Moreover the effect occurred
at 1 h exposure with chlordecone, a time at which the induction of iNOS
is unlikely. In this redox signaling pathway, NOS appears to be a target
of NADPH oxidase since apocynin pre-treatment was shown to decrease
eNOS phosphorylation on its positive regulatory site (Ser 1177).
Consistent with these results, data in the literature including our pre-
vious works on the effects of red wine polyphenol have reported acti-
vation of eNOS by ROS generated by NADPH oxidase (Ndiaye et al.,
2003; Duarte et al., 2004; Duluc et al., 2013). In line also with these
observations, it has recently been shown that angiotensin II stimulation
in cardiac myocytes leads to the activation of NADPH oxidase which in
turn activates Akt and phosphorylates eNOS on the same positive reg-
ulatory site (Jang et al., 2015). Thus, activation of NOS by serine 1177
phosphorylation could be a physiological response to an acute increase
in oxidative stress under normal conditions as suggested by Rafikov.
(Rafikov et al., 2011). The mechanism by which activation of NOS in-
crease mitochondrial ROS production has not been investigated in the
present work but might be related to uncoupling of eNOS, activation of
the redox sensitive PKCε, opening of mitochondrial KATP and sub-
sequent ROS formation secondary to matrix alkalization as reported in
various pathophysiological situations involving mitochondrial redox
signaling (Dikalov et al., 2014a; Malinska et al., 2010). The proposal
mechanism is in line with recent study pointing to the requirement of
NO synthase in activating PKCε to increase VEGF level in abnormal
angiogenesis of diabetic retinopathy (Zhang et al., 2015).
The findings presented here suggest that the mitochondrial O2−
production contribute to increased VEGF expression. Downstream of
mitochondrial O2− production, various redox sensitive mechanisms
that involve translational regulation of VEGF have been described. For
example in hypoxia, O2− generated from mitochondria clustering in
close proximity to the nucleus hypoxia has been shown to stimulate
VEGF expression by increasing the binding of HIF-1 to VEGF promoter
via oxidative DNA modification (Al-Mehdi et al., 2012). Another mi-
tochondrial ROS sensitive mechanism that has often been proposed to
regulate VEGF translation involves activation of the proangiogenic
transcription factor HIF1 (Chang et al., 2014; Hagen, 2012). This in-
creased VEGF expression is expected to drive the angiogenic process.
However, several studies have reported ROS activated angiogenesis
operating in a VEGF independent manner (Kim and Byzova, 2014). As
discussed above, the latter possibility seems plausible at least for the
effect of low chlodecone concentration. Clearly, the role of VEGF in the
chlordecone induced angiogenesis merits further investigation.
Very recently, we reported temporal cross talk between ER and
mitochondria with respect to spatial regulation of O2%− via the neutral
sphyngomyelinase in response to microparticles (Safiedeen et al.,
2017). In the later, this mechanism concurs to endothelial dysfunction.
In the present study, such temporal regulation of oxidative stress is
highlighted and this leads to pro-angiogenic response with regard to
chlordecone. The differential response probably is related to upstream
regulation of mitochondrial ROS: i.e. for microparticles, ER stress is
implicated whereas for chlordecone NADPH oxidase and eNOS pathway
are involved.
Fig. 10. Schematic diagram illustrating the chlordecone induced proangiogenic effect via
ERα and redox signaling and indicating the molecular target of the different inhibitors
used in the study.
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5. Conclusions
In summary, we demonstrate that chlordecone induces angiogenesis
by regulating the production of mitochondrial O2%− via both NADPH
oxidase and NO sensitive pathways (Fig. 10). The chlordecone induced
angiogenesis might be causally implicated in the growing incidence of
prostate cancer in Martinique. (Multigner et al., 2010). Indeed, in this
cancer, the process of angiogenesis, generally referred to as the “an-
giogenic switch” is critical for sustained tumor growth and metastasis
(Huss et al., 2001). Even if chlordecone is probably not the key element
in this switch, it may create an imbalance favoring proangiogenic sti-
muli. Therefore, targeting the pathway involved in the angiogenic effect
of chlordecone pathway could be suitable to manage men with prostate
cancer and high plasma chlordecone concentrations.
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